Zobrazeno 1 - 1
of 1
pro vyhledávání: '"621"'
Autor:
Steven Terra, Robert Frederich, Urszula Masiukiewicz, James P. Mancuso, Silvina Gallo, Brett Lauring, Shrita M. Patel, Mary A. Hickman, Susan Huyck, Susan L. Johnson
Publikováno v:
Diabetes. 67
Ertugliflozin (ERTU) is an SGLT2 inhibitor for the treatment of T2DM. The risk of fracture was assessed in adults with T2DM receiving ERTU relative to placebo (PBO) or active comparator in pooled analyses of 7 randomized, double-blind, Phase 3 trials